Skip to main content
. 2017 Jul 10;8(38):63881–63889. doi: 10.18632/oncotarget.19172

Figure 3. Effect of ATIQCTPC on the number of lung metastasis nodules of LLC sarcoma bearing C57BL/6 mice.

Figure 3

(A) The representative lung of LLC sarcoma bearing C57BL/6 mice orally treated with NS for 11 days (left), the representative lung of LLC sarcoma bearing C57BL/6 mice orally treated with 1 μmol/kg/day of ATIQC for 11 days (middle), and the representative lung of LLC sarcoma bearing C57BL/6 mice orally treated with 0.01 μmol/kg/day of ATIQCTPC for 11 days (right). (B) The number of lung metastasis nodules of LLC sarcoma bearing C57BL/6 mice orally treated with NS(control), ATIQC and ATIQCTPC, n=10.